Brief: Trinity Biotech - Enters ATM Offering Agreement With Lucid Capital Markets For ADS Sale - SEC Filing
12/06/2026 21:29
BRIEF-Trinity Biotech - Enters ATM Offering Agreement With Lucid Capital Markets For ADS Sale - SEC Filing June 12 (Reuters) - Trinity Biotech PLC TRIB.O:
TRINITY BIOTECH - ENTERS ATM OFFERING AGREEMENT WITH LUCID CAPITAL MARKETS FOR ADS SALE - SEC FILING
TRINITY BIOTECH - MAY OFFER AND SELL ADSS UP TO $4.35 MILLION THROUGH LUCID - SEC FILING
Source text: [ID:n0001554855-26-001320]
Further company coverage: TRIB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Trinity Biotech
See all newsNASDAQ RESUMED AT 12:18 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:13 PM
Brief: Trinity Biotech Provides Diagnostics Business, Transformation And Corporate Update
Brief: Trinity Biotech’S Trinovium Subsidiary Agrees To Collaborate With Echelon Data Centres To Develop Advanced Liquid Cooling Solutions For Ai Infrastructure
NASDAQ RESUMED AT 09:00 AM